Nikolaos Kardaras - Rafina Innovations Head Department
| VICA Stock | USD 0.0001 0.00 0.00% |
Insider
Nikolaos Kardaras is Head Department of Rafina Innovations
| Age | 73 |
| Phone | 44 1413 700 321 |
| Web | https://rafina-innovations.com |
Rafina Innovations Management Efficiency
The company has return on total asset (ROA) of (5.9991) % which means that it has lost $5.9991 on every $100 spent on assets. This is way below average. Rafina Innovations' management efficiency ratios could be used to measure how well Rafina Innovations manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Julie Gannon | Vivos Therapeutics | N/A | |
| Shunichi Kuroda | Bone Biologics Corp | N/A | |
| Sam Park | Sight Sciences | 63 | |
| Keith Simeone | STRATA Skin Sciences | N/A | |
| Christopher Lesovitz | STRATA Skin Sciences | 41 | |
| Todd Huntsman | Vivos Therapeutics | N/A | |
| Jonathan Paris | Rapid Micro Biosystems | 48 | |
| Warren Hancock | enVVeno Medical Corp | N/A | |
| Bradford Amman | Vivos Therapeutics | 62 | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| Robert Berman | enVVeno Medical Corp | 61 | |
| John Wilson | Rapid Micro Biosystems | 56 | |
| Jennifer Ernst | Tivic Health Systems | 56 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Benedict MD | enVVeno Medical Corp | 67 | |
| Jesse Selnick | Sight Sciences | N/A | |
| Blake Gurfein | Tivic Health Systems | 40 | |
| Alan Connaughton | LENSAR Inc | 52 | |
| Kendra Wong | LENSAR Inc | 44 | |
| Kevin Vance | Bluejay Diagnostics | 66 | |
| RaeAnn Byrnes | Vivos Therapeutics | N/A | |
Management Performance
| Return On Asset | -6.0 |
Rafina Innovations Leadership Team
Elected by the shareholders, the Rafina Innovations' board of directors comprises two types of representatives: Rafina Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rafina. The board's role is to monitor Rafina Innovations' management team and ensure that shareholders' interests are well served. Rafina Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rafina Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgios Thrapsaniotis, Treasurer, Director | ||
| Paraskevi Pilarinou, Financial Controller | ||
| Constantinos Zertalis, President Director | ||
| Yiannis Levantis, Independent Director | ||
| Hari Elangovan, Acting Officer | ||
| Pr Solomonidis, Head Research | ||
| Paraskevi Pylarinou, CFO, Secretary, Director | ||
| Nikolaos Kardaras, Head Department | ||
| Evaggelia Moschidou, Marketing Director |
Rafina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Rafina Innovations a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -6.0 | |||
| Operating Margin | (12.41) % | |||
| Current Valuation | 1.41 M | |||
| Shares Outstanding | 15.72 M | |||
| Shares Owned By Insiders | 83.44 % | |||
| Price To Earning | (12.98) X | |||
| Price To Sales | 4.05 X | |||
| Revenue | 412.68 K | |||
| Gross Profit | 268.31 K | |||
| EBITDA | (5.76 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rafina Pink Sheet
Rafina Innovations financial ratios help investors to determine whether Rafina Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rafina with respect to the benefits of owning Rafina Innovations security.